tanomastat

Known as: (S)-3-[(4'-Chloro-4-biphenylyl)carbonyl]-2-[(phenylthio)methyl]propionic acid, 4-[4-(chlorophenyl)phenyl]-4-oxo-2S-(phenylthiomethyl) butanoic acid 
A biphenyl matrix metalloproteinase (MMP) inhibitor (MMPI) with potential antineoplastic activity. Tanomastat inhibits MMP-2, MMP-3, and MMP-9… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
OBJECTIVE Azithromycin has become a standard of care in therapy of bronchiolitis obliterans following lung transplantation… (More)
Is this relevant?
2015
2015
Rho family GTPases (including Rac, Rho and Cdc42) collectively control cell proliferation, adhesion and migration and are of… (More)
Is this relevant?
Review
2013
Review
2013
Matrix metalloproteinase (MMP) comprises a family of zinc-dependent endopeptidases that degrade various components of the… (More)
Is this relevant?
Review
2013
Review
2013
Tumour invasion and metastasis have been recognized as major causal factors in the morbidity and mortality among cancer patients… (More)
Is this relevant?
Review
2008
Review
2008
Consolidation therapy is used in order to maximize the benefit of first-line therapy and to improve the progression-free and… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
OBJECTIVE BAY 12-9566 (tanomastat) is a biphenyl matrix metalloprotease inhibitor (MMPI) with antiangiogenic and antimetastatic… (More)
Is this relevant?
2005
2005
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… (More)
Is this relevant?
Review
2002
Review
2002
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… (More)
Is this relevant?